Rasagiline - Teva Pharmaceutical Industries

Drug Profile

Rasagiline - Teva Pharmaceutical Industries

Alternative Names: Agilect; AGN 1135; Azilect; Elbrus; Lu 00-773; Rasagiline mesilate; Rasagiline mesylate; TV-1030; TVP 101; TVP 1012

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Technion - Israel Institute of Technology
  • Developer Lundbeck A/S; Takeda; Teva Pharmaceutical Industries
  • Class Amines; Antiparkinsonians; Indans; Small molecules
  • Mechanism of Action Monoamine oxidase B inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Parkinson's disease
  • Discontinued Alzheimer's disease

Most Recent Events

  • 01 Nov 2018 Takeda plans a post-marketing surveillance study for Parkinson's disease in Japan (JapicCTI-184181)
  • 30 Oct 2018 Launched for Parkinson's disease in Japan (PO) (JapicCTI-184181))
  • 01 Mar 2018 Registered for Parkinson's disease in Japan (PO) (Takeda pipeline, May 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top